Related Experiment Video
Updated: Jun 3, 2026
07:59
Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
Translational research on advanced therapies
Filippo Belardelli1, Paola Rizza, Franca Moretti
1Dipartimento di Biologia Cellulare e Neuroscienze, Istituto Superiore di Sanità, Rome, Italy. filippo.belardelli@iss.it
Annali Dell'Istituto Superiore Di Sanita
|March 25, 2011
Summary
Advanced therapy medicinal products (ATMPs) offer novel treatments for diseases like cancer. Strategic cooperation and research infrastructures are crucial to overcome development challenges and foster translational medicine.
Area of Science:
- Translational medicine and advanced therapy medicinal products (ATMPs).
Background:
- ATMPs, including gene therapy, cell-based products, and tissue-engineered products, represent a significant advancement in therapeutic approaches.
- These therapies hold promise for treating a wide range of diseases such as cancer, neurodegenerative, and cardiovascular conditions.
- Development is hindered by complex regulations, high costs, and the need for specialized Good Manufacturing Practice (GMP) facilities and novel clinical endpoints.
Purpose of the Study:
- To highlight the importance of research infrastructures in advancing translational medicine for ATMPs.
- To discuss ongoing European initiatives aimed at fostering the development and application of advanced therapies.
- To identify and address key bottlenecks in ATMP development and clinical translation.
Main Methods:
- Review of current European initiatives focused on research infrastructures for translational medicine.
- Analysis of the challenges and bottlenecks in the development pathway of advanced therapy medicinal products.
- Discussion on the need for strategic collaboration among academia, industry, and regulatory experts.
Main Results:
- The study identifies significant ongoing European efforts in establishing research infrastructures to support ATMP development.
- It underscores the critical need for multi-stakeholder cooperation to navigate regulatory complexities and financial barriers.
- The potential impact of these initiatives on accelerating the translation of advanced therapies to clinical practice is discussed.
Conclusions:
- Strategic cooperation and dedicated research infrastructures are essential for overcoming ATMP development hurdles.
- European initiatives are actively working to foster translational medicine, aiming to improve patient access to innovative therapies.
- Continued investment and collaboration are vital to realize the full therapeutic potential of advanced therapies.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:29Translational Regulation
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...